Housebuilders dent London's FTSE 100 even as banks gain

by 24britishtvJan. 10, 2022, 11 a.m. 18
-

Jan 10 (Reuters) - UK's blue-chip index slipped in morning trade on Monday as housebuilders were hit by $5.4 billion in costs to remove cladding from buildings, while banking shares extended gains on expectations of interest rate hikes.

The FTSE 100 (.FTSE) was down 0.1% following weekly gains spurred by a rotation into sectors such as banks, oil & gas and mining as investors priced in faster interest rate hikes by major central banks.

Big banks such as HSBC (HSBA.L), Barclays (BARC.L) and Standard Chartered (STAN.L) rose about 1% each, building on last week's gains.

Berkeley Group , Barratt Developments (BDEV.L), Persimmon (PSN.L) and Taylor Wimpey (TW.L) were down between 3.0% and 2.8% after Britain ordered housebuilders to pay around $5.4 billion to help remove dangerous cladding from buildings following a deadly 2017 London fire. read more

Housing minister Michael Gove set an early-March deadline for the industry to agree to a fully funded plan of action, including a dedicated fund to deal with unsafe cladding.

"Given the tone of the letter from Her Majesty's Treasury (against further taxation) it appears their preference is to push the developers to agree to quick remedy for recladding against the backdrop of a threat of legal action," Jefferies analysts said.

Persimmon had the least risk due to its low exposure, while Barratt, Bellway, Berkeley & Taylor Wimpey all had the higher risk of a more meaningful step up in provisions, Jefferies said.

Housebuilders Redrow (RDW.L), Countryside Properties (CSPC.L), Bellway (BWY.L) and Vistry Group (VTYV.L) dropped between 2.8% and 3.7%, while the FTSE 250 index (.FTMC) slipped 0.2%.

Overall, the midcap index slipped 0.2%, adding to weekly losses as a surge in COVID-19 cases due to the Omicron variant hit sentiment.

Plus500 (PLUSP.L) rose 3.1% after the online trading platform said it expects annual results to exceed market expectations, even as it reported slower fourth-quarter growth. read more

Biotech firm Avacta Group (AVCT.L) slumped 22.8% after it said it was halting sales of its COVID-19 antigen lateral flow test, AffiDX, to replace antibodies in the device and boost its ability to detect the Omicron variant at lower viral loads. read more

Reporting by Sruthi Shankar in Bengaluru; Editing by Shounak Dasgupta

-

Related Articles

HOT TRENDS

‘Mindfulness’ monk Thich Nhat Hanh dies aged 95

by 24britishtvJan. 22, 2022, 11 a.m.2
HOT TRENDS

Rafael Nadal through to Australian Open fourth round

by 24britishtvJan. 22, 2022, 3 a.m.2
HOT TRENDS

US comedian Louie Anderson dies aged 68

by 24britishtvJan. 22, 2022, 1 a.m.2
HOT TRENDS

Priyanka Chopra and Nick Jonas welcome their first child

by 24britishtvJan. 22, 2022, 1 a.m.2
HOT TRENDS

Meat Loaf: What exactly is it that the singer would not do for love?

by 24britishtvJan. 22, 2022, 1 a.m.2
HOT TRENDS

BBC The Graham Norton Show: Who is Rachel Zegler?

by 24britishtvJan. 22, 2022, 1 a.m.2
HOT TRENDS

Euromillions results LIVE: Winning Lottery numbers for Friday, January 21

by 24britishtvJan. 22, 2022, 12:20 a.m.2
HOT TRENDS

Rangers ease past Stirling Albion 4-0 in Scottish Cup

by 24britishtvJan. 22, 2022, midnight2
HOT TRENDS

US comedian Louie Anderson dies aged 68

by 24britishtvJan. 21, 2022, 10 p.m.2
HOT TRENDS

'Embarrassed' Adele breaks down in tears as fans rush to support her

by 24britishtvJan. 21, 2022, 10 p.m.2
HOT TRENDS

Rangers vs Stirling Albion - LIVE updates

by 24britishtvJan. 21, 2022, 9:20 p.m.2